Musculoskeletal procedures update

Dec. 2023Important Notices
Effective Feb. 1, 2024, UPMC Health Plan will begin requiring prior authorizations for certain musculoskeletal procedures, which will be evaluated using corresponding Interqual Connect criteria. Those procedures, and the associated procedure codes, are:
  • Arthrodesis or Arthroplasty, Interphalangeal Joint, Second-Fifth Toes
    • CPT codes: 28285, 28286
  • Arthroscopy or Arthroscopically Assisted Surgery, Wrist
    • CPT codes: 25628, 25685, 25695, 29843, 29844, 29845, 29846, 29847
  • Arthroscopy, Surgical, Ankle
    • CPT codes: 29891, 29892, 29894, 29895, 29897, 29898, 29904, 29905, 29906, 29907
  • Arthrotomy, Wrist
    • CPT codes: 25040, 25101, 25105, 25107, 25115, 25118, 25119, 25608, 25609, 25645, 25670, 25676
  • Osteotomy, Distal Transpositional, First Metatarsal (MT) (Bunionectomy)
    • CPT codes: 28296, 28299
  • Osteotomy, Proximal, First Metatarsal (MT) (Bunionectomy)
    • CPT codes: 28295, 28297, 28298
  • Plantar Fascial Release
    • CPT codes: 28008, 28060, 28062, 28250, 29893
  • Reduction and Fixation, Radius +/- Ulna Shaft
    • CPT codes: 25500, 25505, 25515, 25520, 25525, 25526, 25530, 25545, 25560, 25565, 25574, 25575

Authorization coding documentation is available at upmchp.us/PriorAuth as well as the auth entry/inquiry page on Provider OnLine. If you have any questions or concerns about this matter, please contact your physician account executive or call Provider Services at 1-866-918-1595.

Providers are responsible for appropriate billing of services. These suggested codes are not meant to provide or supersede clinical judgment. An authorization is not a guarantee of payment for services rendered.

Recent Announcements

Voluntary nationwide recall: Atorvastatin (Alkem – October)

Ascend Laboratories LLC is recalling multiple lots of Atorvastatin Calcium Tablets USP. Atorvastatin is used for the treatment of high cholesterol and to reduce the risk of certain cardiovascular events, such as heart attack and stroke.
Nov. 2025Pharmacy Updates

October 2025 UPMC for You and UPMC Community HealthChoices formulary update

Effective Oct. 1, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to nonparticipation in the Medicaid Drug Rebate Program.
Oct. 2025Pharmacy Updates

Voluntary nationwide recall: Ocaliva (Intercept – September)

Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).
Oct. 2025Pharmacy Updates